Back to
Invesco Ltd.
AXSM
Showing 8 of 28 quarters
Position history for
Invesco Ltd.'s holdings in Axsome Therapeutics, Inc.
Yes. Invesco holds 1,671,684 shares of AXSM (Axsome Therapeutics), worth $409.2M, as of its Q2 2026 13F filing. It increased the position by 374,006 shares (+28.8%) from Q1 2026. Invesco has held AXSM in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$409.2M
Current Shares
1.7M
Total Value Change
+$353M
Total Shares Change
+1M
Quarter-by-Quarter History